Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PsiFUND: Psilocybin in Functional Neurological Disorder
NCT05723276Completed
- Sponsor
- King's College London
- Start
- Feb 2024
- Primary completion
- Apr 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of psilocybin in Functional Neurological Disorder (FND), sponsored by King's College London. Primary endpoint: Change in functional connectivity in default mode network at 1 week. Started Feb 2024; status: completed.
02
Drugs
psilocybin
03
Conditions
Functional Neurological Disorder (FND)
Beyond the preview
Go deeper on NCT05723276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05723276.